Vorapaxar sulfate
Vorapaxar sulfate, marketed as Zontivity, is a potent oral antagonist of the protease-activated receptor-1 (PAR-1) . It is utilized in research to investigate antiplatelet mechanisms and has been studied in both in vitro assays and in vivo models of thrombosis.
Product Specifications
CAS Number
705260-08-8
Product Name Alternative
Zontivity, Vorapaxar, vorapaxar, vorapaxar monosulfate, vorapaxar Monosulfate, Vorapaxar sulfate, Vorapaxar Sulfate, SCH 530348, SCH 530348 Sulfate, SCH 530348 sulfate, SCH530348, SCH-530348, SCH530348 Sulfate, SCH-530348 Sulfate, Protease Activated Receptor (PAR), Protease-Activated Receptor (PAR), Proteaseactivated Receptor, ProteaseactivatedReceptor, Thrombin receptors, Inhibitor, inhibit, PAR-1
Field of Research
Pharmacology & Drug Discovery
Purity
99.46% (May vary between batches)
Solubility
DMSO:70 mg/mL (118.51 mM)
Smiles
OS (O) (=O) =O.[H][C@@]12C[C@]3 ([H]) C[C@@H] (CC[C@@]3 ([H]) [C@H] (\C=C\c3ccc (cn3) -c3cccc (F) c3) [C@]1 ([H]) [C@@H] (C) OC2=O) NC (=O) OCC
Molecular Formula
C29H35FN2O8S
Molecular Weight
590.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2832481-01 20 µg
Recombinant Human SLC16A1/MCT1 Protein, N-GST & C-His
Sign In for Pricing
View Details orb2832481-02 50 µg
Recombinant Human SLC16A1/MCT1 Protein, N-GST & C-His
Sign In for Pricing
View Details